A Randomized, Multicenter Phase III Clinical Trial Comparing Gemcitabine and Cisplatin With 5-Fluorouracil and Cisplatin in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Trial Profile

A Randomized, Multicenter Phase III Clinical Trial Comparing Gemcitabine and Cisplatin With 5-Fluorouracil and Cisplatin in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Jun 2016

At a glance

  • Drugs Gemcitabine (Primary) ; Cisplatin; Fluorouracil
  • Indications Nasopharyngeal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2016 Results assessing progression free survival presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
    • 11 Jan 2016 Planned end date changed from 1 Dec 2014 to 1 Jun 2017, as reported by ClinicalTrials.gov.
    • 11 Jan 2016 Planned primary completion date changed from 1 Nov 2014 to 1 Jun 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top